MVA-BN-PRO

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameMVA-BN-PRO
Drug Alias NameMVA-BN-PRO
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Recombinant vector vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBn Immunotherapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBavarian Nordic A/S
Active IndicationsN/A
Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A